Cargando…
Analytical toxicology for clinical, forensic, and pharmaceutical chemists /
Aimed at toxicologists and pharmacists involved in analytical work, this text provides critical evaluations of analytical possibilities to help with the choice of methods.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Berlin ; New York :
W. de Gruyter,
1997.
|
| Colección: | Clinical biochemistry ;
5. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Part 1 Chapters of General Nature; 1.1 Emergency Toxicology (M. Schmidt and M. Roth); 1.2 Therapeutic Drug Monitoring (A. D. Fraser); 1.3 Special Aspects of Forensic Toxicology (H. Brandenberger); 1.4 Analytical Aspects of Doping in Sports (D. de Boer, T. J. A. Seppenwoolde-Waasdorp and R. A. A. Maes); 1.5 Pharmacokinetics as Applied to Drug and Doping Research (T. B. Vree); 1.6 The Future of Immunochemical Drug Analysis (T. Takatori and M. Nagao); 1.7 The Future of Instrumental Analysis in Toxicology (H. Brandenberger); Part 2 Chapters Concerned with Special Poison Classes.
- 2.1 Natural Gases and Vapors (H. Brandenberger)2.2 Carbon Monoxide (T. Kojima); 2.3 Determination of Alcohol Levels in the Body (H. Brandenberger, R. Brandenberger and K. Halder); 2.4 Volatile Hydrocarbons (T. Nagata and K. Kimura); 2.5 Volatile Halogenated Compounds (R. J. Flanagan); 2.6 Pesticides (M. Geldmacher-v. Mallinckrodt and G. Machbert); 2.7 Glycols (M. Roth); 2.8 Inorganic Anions (M. Roth); 2.9 Non-Metals of Group 16 (M. Roth and M. Pelletier); 2.10 Metals of Toxicological Significance (H. Brandenberger and M. Roth)
- 3.3 Hypnotics and Sedatives Not Belonging to the Classes of Barbiturates and Benzodiazepines (H. Brandenberger)Part 3 Toxicological Drug Analysis; 3.1 Barbiturates (H. Brandenberger); 3.2 Benzodiazepines (H. Schütz); 3.4 Anticonvulsants Not Belonging to the Classes of Barbiturates and Benzodiazepines (W. R. Külpmann); 3.5 Neuroleptics (R. Whelpton); 3.6 Antidepressants (R. A. Braithwaite); 3.7 Beta-Blocking Drugs (M. S. Leloux); 3.8 Analgesics, Antipyretics and Non-Steroidal Anti-Inflammatory Agents (B. Widdop); 3.9 Antihistamines (H. Brandenberger)
- 3.10 Volatiles Used and Abused as Anesthetics (H. Brandenberger)3.11 Digitalis (= Cardiac) Glycosides (J. Hallbach and H. Vogel); 3.12 Cyclosporins (D. W. Holt); 3.13 Anticoagulants (M. Geldmacher-v. Mallinckrodt); 3.14 Alkaloids (Y. Kuroiwa and T. Yoshida); 3.15 Stimulants (D. de Boer, T. J. A. Seppenwoolde-Waasdorp and R. A. A. Maes); 3.16 Designer Drugs (G. L. Henderson); Part 4 Blood Level Data; 4.1 Blood Level Data (D. R. A. Uges); Index.